在视网膜退化过程中,乌比基因化和蛋白质稳定性的进展
Jia Wei1, Xiaona Chen1, Yingyue Xiong1
1Department of Ophthalmology, The Second Clinical Medical College of Jinan University, 518020 Shenzhen, Guangdong, China.
Frontiers in bioscience (Landmark edition)
|July 31, 2024
概括
乌比基化是一种关键的蛋白质修饰过程,对视网膜健康至关重要. 它的失调有助于视网膜退化 (RD),提供潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
背景情况:
- 视网膜退化 (RD) 涉及逐渐的视网膜细胞死亡,导致视力丧失.
- 视网膜平衡和功能对于 RD 病原和治疗至关重要.
- 通过蛋白质的修饰和降解,乌比基因化对于维持视网膜平衡和正常功能至关重要.
研究的目的:
- 审查近期在理解RD病变发生过程中与ubiquitin相关的基因和蛋白质方面的进展.
- 总结基于无处不在途径的 RD 潜在的有针对性的治疗策略.
- 为开发基于无处不在的RD治疗方法提供指导.
主要方法:
- 在R&D中对与ubiquitin相关的基因,蛋白质和蛋白质平衡的综合文献综述.
- 分析了在视网膜蛋白质降解中,乌比奎丁-蛋白酶体系统和自-溶酶体系统的作用.
- 探索被破坏的无处不在和研发和开发发展之间的联系.
主要成果:
- 乌比基化在通过两个主要的降解系统来维持视网膜蛋白质平衡中发挥着核心作用.
- 无处化或蛋白质平衡的失调可以导致RD的发展.
- 特定的与ubiquitin相关的途径与视网膜细胞死亡的进展有关.
结论:
- 准无处不在的途径为视网膜退化提供了一个有希望的治疗途径.
- 了解蛋白质稳态对于开发有效的RD治疗非常重要.
- 对无处不在机制的进一步研究可以指导对致盲疾病的新型治疗策略.
更多相关视频
10:25Monitoring of Ubiquitin-proteasome Activity in Living Cells Using a Degron dgn-destabilized Green Fluorescent Protein GFP-based Reporter Protein
Published on: November 10, 2012
16.7K
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
2.5K
相关概念视频
02:58Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
01:13The Proteasome
822
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
822
01:32Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K